Abstract-The effect of piroxicam on polymorphonuclear neutrophils (PMN) functions induced by several stimuli was evaluated in vitro. Preincubation of rabbit or human PMN with piroxicam inhibited the cellular responses elicited by N-formylmethionyl-leucyl-phenylalanine (FMLP) such as superoxide anion (O2-) generation, granule enzyme release and chemotaxis. The effectiveness of piroxicam on each response was superior to those of indomethacin and ibuprofen. Also when either concanavalin A, zymosan-treated serum or ionophore A23187 was used as stimuli, piroxicam inhibited O2-generation of PMN. The inhibitory effect of piroxicam on FM LP-induced O2-generation was dependent on the concentration of stimuli and was reversed, by increasing the extracellular calcium concentration.
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In addition, piroxicam had no effect on the activity of a chymotrypsin-like esterase, N-acetylphenylalanine-8-naphthyl esterase, isolated from rabbit PMN. These results suggest that at least some of the anti-inflammatory effects of piroxicam may be mediated by affecting PMN functions, and the inhibition of Of generation of PMN by piroxicam may be related to its capacity to modulate the association of calcium with these cells.
Piroxicam is a structurally novel, nonsteroidal anti-inflammatory agent with an enloic group (1) . Studies using experimental animals have established that piroxicam is a long-acting, potent inhibitor of the inflammatory response (2, 3) . Furthermore, we have reported that piroxicam possesses more potent activity in the inflammatory models mediated by allergic reactions; and we also suggested that in addition to inhibiting prostaglandin synthesis (2, 4) , it may exert anti-inflammatory effects by regulating several other functions of inflammatory cells (5).
Polymorphonuclear neutrophils (PM N) are important elements in a variety of immunologically triggered reactions. These phagocytic cells, in response to various surface stimuli, discharge the granule-associated enzymes and generate superoxide anion (02-) (6, 7). Both the enzymatic constituents and the highly reactive molecules cause much of the tissue injury associated with the inflammatory process (8, 9).
In this paper, we report that piroxicam is a potent inhibitor of PMN responses stimulated with the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (FMLP). Since the inhibition of PMN responses in the presence of piroxicam was assumed to be due to a variety of causes such as interference with receptor-ligand interactions (10), inactivation of various critical surface enzymes (11-13), and impediment of the association of calcium with these cells (14-16), the present studies were undertaken to elucidate these points.
Materials and Methods Preparation of cell suspension:
Rabbit peritoneal PMN were obtained 4 to 5 hr after the peritoneal injection of 0.1% sterile glycogen (11). The cells were, if necessary, freed of erythrocytes by hypotonic lysis and washed twice in Dulbecco's phosphate buffered saline (pH 7.4). The proportion of PMN obtained in this manner averaged 95%. 
Results
Effect on O2-generation: Table 1 shows that piroxicam inhibited 10-7 M FMLPinduced 02-generation of rabbit PMN in a dose-dependent fashion. The concentration of piroxicam which inhibited 02-generation by 50% (IC50) was about 100 pM. The same result was obtained in human PMN, and the IC50 of piroxicam in this case was about 50 tiM. The inhibitory effect of piroxicam was observed throughout the incubation (data not shown). lndomethacin (100 ,uM) and ibuprofen (300 pM) inhibited the 02-generation by human PMN; however, neither had any effect. on that by rabbit PMN at the respective concentrations.
Effect on release of granule-associated enzyme: Human PMN pretreated with cytochalasin B released 37.6±1.7% and 55.6±3.3% of the total 8-glucuronidase and lysozyme activity, respectively, in the presence of 10-7 M FMLP for 5 min. The significant release of lactate dehydrogenase, a cytoplasmic enzyme, was not detected during the incubation. As shown in Table 2 , piroxicam, indomethacin and ibuprofen in hibited FMLP-induced selective release of a9-glucuronidase and lysozyme from human PMN. The relative effects of the test compounds indicate that piroxicam=indo-methacin > ibuprofen.
Effect on chemotaxis: To examine the effect of piroxicam on in vitro migration of rabbit PMN, 10-9 M FMLP was used as the attractant. This concentration was chosen because it gave a maximal response in some preliminary experiments. The results in Table  3 reported to act as a competitive antagonist for the receptor of synthetic chemotactic peptides on PMN (10) and TPCK has been shown to inhibit 02-formation by inactivating the serine proteases located at the cell surface membrane (12), both agents were used as comparative test compounds. Figure 1 shows that the preincubation with piroxicam (100 dose-response curve, i.e., the inhibitory effect of piroxicam was dependent on the concentration of FMLP. The same shift, as seen in Fig. 1 A, was observed in the treatment with CBZ-phe-met (30 tiM, 100 teM) , which was in good agreement with the findings of Becker et al. (25) . On the other hand, TPCK (10 tiM) showed an inhibition independent of the concentration of FM LP by about 50% (Fig. 1 B) . It seems that the inhibition by TPCK is associated with the irreversible inactivation of serine proteases required for rabbit PMN are shown in Fig. 2 . Piroxicam (100 pM) inhibited Con A-induced 02-generation, and the pattern of its inhibitory effect was similar to that of FM LP. However, CBZ-phe-met (100 pM) had no effect on with TPCK (10 pM) caused nearly complete inhibition within the range of Con A concentrations used for this study.
exposing cytochalasin B-treated PMN to 10% autologous ZTS and to 10 tiM ionophore A23187, which is known to stimulate calcium influx into various cells. Fig. 3 . A calcium concentration between 0.6 and 2.4 mM stimulated a graded enhancement of O2-generation in the presence of 10-7 M FMLP. It should be noted that calcium alone failed to induce O2-generation of PMN in the absence of FM LP. Inhibition of O2-generation by piroxicam (100 tiM) was demonstrated with an extracellular calcium concentration of 0 to 1.2 mM. Increasing the calcium concentration to 1.8 or 2.4 mM significantly attenuated the capacity of piroxicam to inhibit FMLP-induced 02-generation. The same tendency was observed in the inhibition by CBZ-phe-met (100 tiM). However, the inhibitory effect of TPCK (3 tiM) was scarcely affected by the extracellular calcium concentration.
Effect of piroxicam on the activity of Acphe-Onap esterase: To examine whether piroxicam has an inactivating action on serine proteases like TPCK (26), we isolated Ac-phe-Onap esterase, a chymotrypsin-like esterase, from rabbit PMN and tested the effect of piroxicam on this esterase activity. Table 5 shows that piroxicam and indomethacin, which had been preincubated with enzyme samples for 3 hr at a concentration of 1 mM before adding the substrate, had no effect on this enzyme activity. On the other hand, evident inhibition of the esterase activity was observed in the presence of 0.1 mM or more of TPCK.
Discussion
There have been numerous reports on the effects of non-steroidal anti-inflammatory Table 5 . Effect of piroxicam, indomethacin and TPCK on the activity of N-acetyl-phenylalanine-19-naphthyl esterase isolated from rabbit PMN The esterase assay is described in Materials and Methods.
Each value is the mean+S.E. of 3 separate experiments.
Mean activity in the control assays was 49 .47+6.36 nmol naphthol produced/15 min. **P<0 .01 (significantly different from the control).
agents on 02-generation (27-29), granule enzyme release (14, 30, 31) and chemotaxis (32, 33) of phagocytic cells stimulated with various stimuli. However, the results in the effects of certain drugs vary depending upon cell types and stimuli used. In addition, the mechanism by which non-steroidal antiinflammatory agents retard chemotactic factor-induced PMN responses remains conjectural. Recently, with regard to 02-generation of PMN, Kitagawa et al. (12, 34) have proposed that chymotrypsin-like serine proteases are essential for these cells to initiate and maintain the 02-generation in response to stimuli, and they also suggested that these proteases might be involved in the activation of NAD(P)H oxidase which is the primary enzyme for 02-production. It seems that the chymotrypsin type proteases are also required for chemotaxis (23) and degranulation (35) of PMN. The primary purpose of this study, therefore, was to evaluate the effect of piroxicam on these cellular responses in vitro and to clarify whether or not piroxicam influences 02-generation by modifying the critical surface enzyme, serine proteases, as does TPCK, an irreversible inhibitor of these enzymes (12).
The data presented here show that piroxicam inhibits the PMN responses elicited by FMLP such as 02-generation, granule enzyme release and chemotaxis, and the effectiveness of piroxicam on each response is superior to those of indomethacin and ibuprofen. The rank order of these compounds correlates with their ability to suppress the inflammatory process in experimental models mediated by allergic reactions (5). These results strongly suggest that part of the antiinflammatory actions of piroxicam may be related to the curtailment of production or release of deleterious materials from PMN. Furthermore, it is likely that this action of piroxicam is extended to other inflammatory cells like macrophages. Indeed, Scheinberg et al. (36) have reported that piroxicam inhibits not only PMN chemotaxis but also monocyte chemotaxis.
The concentration of piroxicam demonstrating the inhibition of PMN functions may be somewhat higher than the free plasma levels achieved in man with therapeutic doses.
One possible explanation of this difference would be that the experimental conditions employed in this study were set up to give a maximal response for each PMN function. The inhibitory effect of piroxicam on FMLPinduced 02-generation was dependent upon the concentration of stimuli. Therefore, if experiments are performed with a suboptimal FMLP concentration, the concentration of piroxicam required to effectively curtail the PMN responses may be approximate to that achieved at the site of action in vivo.
On FMLP-induced 02-generation of rabbit PMN, piroxicam showed seemingly competitive inhibition as observed with CBZphe-met. On the other hand, when Con A was used as the stimulus, piroxicam inhibited 02-generation in the same manner, but CBZphe-met did not. Also, CBZ-phe-met had no effect on 02-generation stimulated with ZTS and A23187, but piroxicam inhibited this 02-generation uniformly. In this aspect, the action of piroxicam resembled that of TPCK. Edelson et al. (37) have also found that piroxicam inhibited the aggregation, 02-generation and lysozyme secretion shown by human PMN stimulated with FMLP. When Con A or phorbol myristate acetate (PMA) was the stimulus, however, aggregation and lysozyme secretion were normal in the presence of piroxicam, while 02-generation was inhibited. The binding of [31-1]-FMLP to PMN was also inhibited by piroxicam, but that of [31-I]-Con A was not. These findings and our data suggest that the effect of piroxicam on 02-generation is not specific to the peptide receptor on PMN, in contrast with CBZ-phe-met (25), but is due to the inhibition of a specific step in the activation of the 02-generating system of PMN, which is common to all the stimuli used.
Because there is the possibility that the above step is the serine proteases which TPCK can inactivate, we examined the effect of piroxicam on a chymotrypsin-like esterase capable of splitting the Ac-phe-Onap ester of rabbit PMN. This esterase has been implicated in the chemotactic response (23) and has been reported to exist in the plasma membrane fraction of rabbit PMN (38). As shown in Table 5 , piroxicam had no effect on the activity of this enzyme but TPCK inhibited it.
There are still points to be clarified as to the possible participation of this protease in O2-production by PMN; however, it is unlikely that the effect of piroxicam on O2-generation is due to the inhibition of serine proteases.
Recent reports indicate that in the PMN activation by stimuli, calcium plays an important role (15, 16, 25) . The stimulation of PMN with FMLP is associated with calcium ion influx across the plasma membrane (39) and a loss of membrane-bound calcium (40). Relative to this point, Edelson et al. (37) have studied the effect of piroxicam on the changes in the fluorescence of chlorteracycline (CTC)-preloaded PMN, which have been attributed to mobilization of membranebound calcium. They have noted that the characteristic decrements in CTC fluorescence, exhibited by PMN when they were activated by FMLP, Con A and PMA, were inhibited in the presence of piroxicam. This observation is important in studying the precise mechanism of action of piroxicam.
We have shown that piroxicam inhibits A23187-induced O2-generation of rabbit PMN, and further, the effect of piroxicam on FMLP-induced O2-generation is reversed by increasing the extracellular calcium concentration. These observations correspond with those of Smith (14) . He has demonstrated that the capacity of non-steroidal antiinflammatory agents such as indomethacin to inhibit A23187-induced secretion of 8-glucuronidase from guinea pig PMN could be attenuated by the calcium, but not magnesium, concentration of the medium. Our findings also support the possibility that non-steroidal anti-inflammatory agents including piroxicam inhibit FM LP-induced of calcium with PMN, as proposed by Smith and Iden (31) in the case of the granule enzyme release.
It is unknown whether these effects of nonsteroidal anti-inflammatory agents might be mediated through prostaglandin metabolism or other intermediary effects independent of prostaglandin. The reports that exogenous prostaglandins inhibited FMLP-induced extrusion of lysosomal enzyme from cytochalasin B-treated human PMN (31) and that acetylsalicylic acid had no significant effect on FMLP-induced O2-generation of human PMN (29) do not support the above mentioned prostaglandin-dependent mechanism. Quite recently, however, the interaction between intracellular calcium levels and the metabolism of phosphatidylinositol or the activity of phospholipase A2 have been revealed (41, 42). Thus, the modulation of the association of calcium with PMN may affect the release of arachidonic acid from the cell membrane. On the other hand, the fact that the inhibitory effect of TPCK was not influenced by extracellular calcium concentration may provide the information as to the role of serine proteases in O2-generation by PMN.
In summary, the data presented here demonstrate that piroxicam has the capacity to inhibit PMN responses such as O2-generation, granule enzyme release and chemotaxis resulting from cell contact with the chemotactic peptide. The inhibition of ZTS and A23187 indicates that the effect of piroxicam can not be due to the interference of receptor-ligand binding, but must be due to the inhibition of an activation step of the O2-generating system of PM N which is common to all the stimuli used.
However production in macrophages by anti-inflammatory
